Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000687751 | SCV000815337 | pathogenic | Charcot-Marie-Tooth disease dominant intermediate C | 2023-09-23 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 567612). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on YARS protein function. This missense change has been observed in individuals with autosomal recessive YARS-related conditions (PMID: 29302074, 31130284, 34536092). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs376054085, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 367 of the YARS protein (p.Arg367Trp). |
Institute of Human Genetics, |
RCV001264808 | SCV001442999 | pathogenic | recessive ARS-related multisystem disease | 2020-06-01 | criteria provided, single submitter | clinical testing | PS1, PM2, PM3, PP1_Strong, PP3 |
Gene |
RCV001584557 | SCV001812954 | likely pathogenic | not provided | 2024-05-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29302074, 31130284, 16429158, 34536092, 38125821) |
Athena Diagnostics | RCV001662751 | SCV001879895 | likely benign | not specified | 2021-05-05 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV002226737 | SCV002505683 | pathogenic | Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2 | 2022-05-03 | criteria provided, single submitter | clinical testing |